Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toujeo versus standard basal insulin in uncontrolled type 2 diabetes
2015-001832-39Phase 4Completed
- Sponsor
- Sanofi
- Start
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Toujeo transition arm with Standard of care basal insulin arm (2 arms). Primary endpoint: Change in HbA1c. Started Aug 2015; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-001832-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001832-39.